PCM
VRTX icon

Palisade Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Palisade Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,593
Closed -$424K – 542
2015
Q1 		$424K Hold
3,593
– – 0.01% 457
2014
Q4 		$427K Sell
3,593
-253
-7% -$28.5K 0.01% 438
2014
Q3 		$432K Sell
3,846
-170
-4% -$16.2K 0.01% 440
2014
Q2 		$380K Sell
4,016
-751
-16% -$52.7K 0.01% 435
2014
Q1 		$337K Sell
4,767
-3,615
-43% -$286K 0.01% 429
2013
Q4 		$623K Sell
8,382
-4,488
-35% -$313K 0.02% 376
2013
Q3 		$976K Sell
12,870
-2,129
-14% -$169K 0.03% 351
2013
Q2 		$1.2M Buy
+14,999
New +$1.1M 0.03% 352

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return